Pharmacist's Letter | CE & Recommendations You Can Trust

October 2024 Issue

Explain How Epinephrine Nasal Spray Compares to Injectables

You’ll hear buzz about Neffy, the first epinephrine NASAL SPRAY for treating severe allergic reactions including anaphylaxis...

Resources

FAQ: Emergency Epinephrine Devices
FAQ: Managing Anaphylaxis

Expect Big Changes to Medicare Part D in 2025

Patients will ask about changes coming to Medicare Part D in 2025...

To D or Not to D…That Is the Question

New guidelines will reignite controversy over when to recommend vitamin D supplementation in adults and whether to check levels...

Consider Medical History When Recommending a Contraceptive

We’re getting questions about tailoring contraceptives for special populations...

GO TO FULL ISSUE

CE & Training

INTERACTIVE SELF-STUDY CE: Alternative Modalities for Mental Health

CE IN THE LETTER: Pharmacist's Letter October 2024

LIVE CE: Pharmacy Essential Updates October 2024

PODCAST CE: Medication Talk - Asthma and COPD Treatment

GO TO CE & TRAINING ORGANIZER >

Free Clinical Resources

Meds That Should Not Be Crushed

Flu Vaccines for 2024-25 (United States)

Comparison of GLP-1 Agonists

GO TO ALL CLINICAL RESOURCES >

What is Pharmacist’s Letter?

Pharmacist's Letter is the resource trusted by over 200,000 pharmacists for staying current on medication recommendations and taking and tracking CE. Learn more >

Free CE for Pharmacists

Pharmacist's Letter offers ACPE-accredited CE at no charge to help pharmacists meet license renewal requirements. Claim your free CE now:

Group Purchases & Pricing

Pharmacist’s Letter is eligible for bulk discounts. Customize CE and compliance training assignments. Easily manage users and run reports. Bundle with other products for significant savings. Request information